⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for pegylated recombinant human hyaluronidase ph20

Every month we try and update this database with for pegylated recombinant human hyaluronidase ph20 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic CancerNCT04058964
Metastatic Panc...
Stage IV Pancre...
Pegylated Recom...
Pembrolizumab
18 Years - M.D. Anderson Cancer Center
A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLCNCT02346370
Non-small Cell ...
PEGylated recom...
Docetaxel
18 Years - Halozyme Therapeutics
A Phase 1b Study of PEGylated Recombinant Human Hyaluronidase (PEGPH20) Combined With Docetaxel in Subjects With Recurrent Previously Treated Locally Advanced or Metastatic NSCLCNCT02346370
Non-small Cell ...
PEGylated recom...
Docetaxel
18 Years - Halozyme Therapeutics
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: